May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Lotrafilcon–A Contact Lens for Corneal Endothelium Polymegatism Secundary to Contact Lens Use
Author Affiliations & Notes
  • F.C. Abib
    Anatomy, Federal, Curitiba, Brazil
  • Footnotes
    Commercial Relationships  F.C. Abib, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 105. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F.C. Abib; Lotrafilcon–A Contact Lens for Corneal Endothelium Polymegatism Secundary to Contact Lens Use . Invest. Ophthalmol. Vis. Sci. 2006;47(13):105.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Study of corneal endothelium polymegatism changes in long time hydrogel contact lens (HCL) users when the contact lens (CL) material was changed for lotrafilcon–A.

Methods: : Prospective study of 14 eyes with diagnosis of severe polymegatism with Bio–Optics contact specular microscopy. Coefficient of variation (CV) was used to measure corneal endothelial polymegatism. The follow up of corneal polymnegatism after the change of HCL to lotrafilcon–A (Focus Night&Day): every 3 months for 18 months; p<0,05 indicate statistic significance.

Results: : The effect of HCL is the same for all eyes, exist different magnitude of CV endothelial behaviour when the material of CL was changed for lotrafilcon–A (p=0,0001) and significant tendency to decrease during the time (p<0,0001, angle coeficient –0,00817 and confidence limits 95%: –0,012006 to –0,00434).

Conclusions: : The lotrafilcon–A may decrease severe corneal polymegatism secondary long time HCL users.

Keywords: cornea: endothelium • contact lens • imaging/image analysis: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×